Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (121-130 of 596) with videos related to

Pageof 60
Sort By:
Infectious Diseases and Therapy|November 21, 2014
Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)Wonhee So, Joseph L Kuti, David P Nicolau
Antibiotics (Basel, Switzerland)|August 26, 2022
Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and StrategiesElaine Liu, Kristin E Linder, Joseph L Kuti
Expert Review of Anti-Infective Therapy|December 7, 2024
Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by <i>Acinetobacter baumannii</i>Yakun Fu, Tomefa E Asempa, Joseph L Kuti
Nigerian Journal of Clinical Practice|September 30, 2024
Integration of Primary Preventive Care of Cardiovascular Disease in a Retroviral Clinic in an adult retroviral clinic in Ibadan: A retrospective studyM A Kuti, K M Kuti, O A Awolude, et al.
Seminars in Respiratory and Critical Care Medicine|February 10, 2009
Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumoniaKathryn J Eagye, David P Nicolau, Joseph L Kuti
African Health Sciences|June 11, 2015
Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, NigeriaKuti Bankole Peter, Adegoke Samuel Ademola, Oyelami Akibu Oyeku
Expert Opinion on Pharmacotherapy|February 8, 2018
Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteriaJames M Kidd, Joseph L Kuti, David P Nicolau
Expert Opinion on Pharmacotherapy|January 30, 2007
Intra-abdominal infections: considerations for the use of the carbapenemsIoannis P Kioumis, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy|June 25, 2004
Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002Joseph L Kuti, Charles H Nightingale, David P Nicolau
Journal of Chromatographic Science|May 10, 2011
Development of an HPLC method for the determination of anidulafungin in human plasma and salineChristina A Sutherland, David P Nicolau, Joseph L Kuti
Pageof 60

Showing results (121-130 of 596) with videos related to

Sort By:
Pageof 60
Infectious Diseases and Therapy|November 21, 2014
Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)Wonhee So, Joseph L Kuti, David P Nicolau
Antibiotics (Basel, Switzerland)|August 26, 2022
Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and StrategiesElaine Liu, Kristin E Linder, Joseph L Kuti
Expert Review of Anti-Infective Therapy|December 7, 2024
Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by <i>Acinetobacter baumannii</i>Yakun Fu, Tomefa E Asempa, Joseph L Kuti
Nigerian Journal of Clinical Practice|September 30, 2024
Integration of Primary Preventive Care of Cardiovascular Disease in a Retroviral Clinic in an adult retroviral clinic in Ibadan: A retrospective studyM A Kuti, K M Kuti, O A Awolude, et al.
Seminars in Respiratory and Critical Care Medicine|February 10, 2009
Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumoniaKathryn J Eagye, David P Nicolau, Joseph L Kuti
African Health Sciences|June 11, 2015
Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, NigeriaKuti Bankole Peter, Adegoke Samuel Ademola, Oyelami Akibu Oyeku
Expert Opinion on Pharmacotherapy|February 8, 2018
Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteriaJames M Kidd, Joseph L Kuti, David P Nicolau
Expert Opinion on Pharmacotherapy|January 30, 2007
Intra-abdominal infections: considerations for the use of the carbapenemsIoannis P Kioumis, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy|June 25, 2004
Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002Joseph L Kuti, Charles H Nightingale, David P Nicolau
Journal of Chromatographic Science|May 10, 2011
Development of an HPLC method for the determination of anidulafungin in human plasma and salineChristina A Sutherland, David P Nicolau, Joseph L Kuti
Pageof 60